278 related articles for article (PubMed ID: 23398374)
1. HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype.
Howson JM; Roy MS; Zeitels L; Stevens H; Todd JA
Diabet Med; 2013 Jun; 30(6):710-6. PubMed ID: 23398374
[TBL] [Abstract][Full Text] [Related]
2. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
[TBL] [Abstract][Full Text] [Related]
3. HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes.
Noble JA; Johnson J; Lane JA; Valdes AM
Diabetes; 2013 Sep; 62(9):3292-9. PubMed ID: 23801574
[TBL] [Abstract][Full Text] [Related]
4. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region).
Petrone A; Bugawan TL; Mesturino CA; Nisticò L; Galgani A; Giorgi G; Cascino I; Erlich HA; Di Mario U; Buzzetti R
Tissue Antigens; 2001 Dec; 58(6):385-94. PubMed ID: 11929589
[TBL] [Abstract][Full Text] [Related]
5. A cis-eQTL of HLA-DRB1 and a frameshift mutation of MICA contribute to the pattern of association of HLA alleles with cervical cancer.
Chen D; Gyllensten U
Cancer Med; 2014 Apr; 3(2):445-52. PubMed ID: 24520070
[TBL] [Abstract][Full Text] [Related]
6. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility to multiple sclerosis in African Americans.
Goodin DS; Oksenberg JR; Douillard V; Gourraud PA; Vince N
PLoS One; 2021; 16(8):e0254945. PubMed ID: 34370753
[TBL] [Abstract][Full Text] [Related]
8. Family-based association study of HLA class II with type 1 diabetes in Moroccans.
Drissi Bourhanbour A; Benseffaj N; Ouadghiri S; Razine R; Touzani A; Belafraj A; Essakalli M
Pathol Biol (Paris); 2015 Apr; 63(2):80-4. PubMed ID: 25555495
[TBL] [Abstract][Full Text] [Related]
9. Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.
Onengut-Gumuscu S; Chen WM; Robertson CC; Bonnie JK; Farber E; Zhu Z; Oksenberg JR; Brant SR; Bridges SL; Edberg JC; Kimberly RP; Gregersen PK; Rewers MJ; Steck AK; Black MH; Dabelea D; Pihoker C; Atkinson MA; Wagenknecht LE; Divers J; Bell RA; ; ; Erlich HA; Concannon P; Rich SS
Diabetes Care; 2019 Mar; 42(3):406-415. PubMed ID: 30659077
[TBL] [Abstract][Full Text] [Related]
10. Race-specific type 1 diabetes risk of HLA-DR7 haplotypes.
Noble JA; Johnson J; Lane JA; Valdes AM
Tissue Antigens; 2011 Nov; 78(5):348-51. PubMed ID: 21988721
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
Arnett FC; Gourh P; Shete S; Ahn CW; Honey RE; Agarwal SK; Tan FK; McNearney T; Fischbach M; Fritzler MJ; Mayes MD; Reveille JD
Ann Rheum Dis; 2010 May; 69(5):822-7. PubMed ID: 19596691
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.
Caillier SJ; Briggs F; Cree BA; Baranzini SE; Fernandez-Viña M; Ramsay PP; Khan O; Royal W; Hauser SL; Barcellos LF; Oksenberg JR
J Immunol; 2008 Oct; 181(8):5473-80. PubMed ID: 18832704
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls.
Mbanya JC; Sobngwi E; Mbanya DN
Eur J Immunogenet; 2001 Aug; 28(4):459-62. PubMed ID: 11532022
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations.
Alcina A; Abad-Grau Mdel M; Fedetz M; Izquierdo G; Lucas M; Fernández O; Ndagire D; Catalá-Rabasa A; Ruiz A; Gayán J; Delgado C; Arnal C; Matesanz F
PLoS One; 2012; 7(1):e29819. PubMed ID: 22253788
[TBL] [Abstract][Full Text] [Related]
15. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.
Viken MK; Blomhoff A; Olsson M; Akselsen HE; Pociot F; Nerup J; Kockum I; Cambon-Thomsen A; Thorsby E; Undlien DE; Lie BA
Genes Immun; 2009 Jun; 10(4):323-33. PubMed ID: 19295542
[TBL] [Abstract][Full Text] [Related]
16. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
[TBL] [Abstract][Full Text] [Related]
18. Haplotype-based search for SNPs associated with differential type 1 diabetes risk among chromosomes carrying a specific HLA DRB1-DQA1-DQB1 haplotype.
McGinnis R; McLaren W; Ranganath V; Whittaker P; Hunt S; Deloukas P;
Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(0 1):8-16. PubMed ID: 19143810
[TBL] [Abstract][Full Text] [Related]
19. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles.
Hu CY; Allen M; Chuang LM; Lin BJ; Gyllensten U
Hum Immunol; 1993 Oct; 38(2):105-14. PubMed ID: 8106265
[TBL] [Abstract][Full Text] [Related]
20. The rare HLA-DQA1*03-DQB1*02 haplotype confers susceptibility to type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects.
van Autreve JE; Weets I; Gulbis B; Vertongen F; Gorus FK; van der Auwera BJ;
Hum Immunol; 2004 Jul; 65(7):729-36. PubMed ID: 15301863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
